Ashley McEvoy's most recent trade in Procter & Gamble Co. was a trade of 161 Common Stock done . Disclosure was reported to the exchange on March 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| P&G | Ashley A. McEvoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 161 | 5,751 (0%) | 0% | 0 | Common Stock | |
| Insulet | Ashley A. McEvoy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 26,143 | 26,143 | - | - | Employee Stock Option (Right to Buy) | |
| Insulet | Ashley A. McEvoy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 10,046 | 23,962 (0%) | 0% | 0 | Common Stock | |
| Insulet | Ashley A. McEvoy | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 239.35 per share. | 20 Feb 2026 | 4,300 | 13,916 (0%) | 0% | 239.4 | 1,029,205 | Common Stock |
| P&G | Ashley A. McEvoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2025 | 215 | 5,562 (0%) | 0% | 0 | Common Stock | |
| P&G | Ashley A. McEvoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2025 | 1,475 | 5,318 (0%) | 0% | 0 | Common Stock | |
| P&G | Ashley A. McEvoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2025 | 189 | 3,843 (0%) | 0% | 0 | Common Stock | |
| P&G | Ashley A. McEvoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 185 | 3,636 (0%) | 0% | 0 | Common Stock | |
| Insulet | Ashley A. McEvoy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 24,150 | 24,150 | - | - | Employee Stock Option (Right to Buy) | |
| Insulet | Ashley A. McEvoy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 9,540 | 9,540 (0%) | 0% | 0 | Common Stock | |
| P&G | Ashley McEvoy A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 145 | 3,433 (0%) | 0% | 0 | Common Stock | |
| P&G | Ashley McEvoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 175 | 3,273 (0%) | 0% | 0 | Common Stock | |
| P&G | Ashley McEvoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 1,309 | 3,082 (0%) | 0% | 0 | Common Stock | |
| P&G | Ashley McEvoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 169 | 1,773 (0%) | 0% | 0 | Common Stock | |
| P&G | Ashley McEvoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 180 | 1,597 (0%) | 0% | 0 | Common Stock | |
| P&G | Ashley McEvoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 155 | 1,409 (0%) | 0% | 0 | Common Stock | |
| P&G | McEvoy Ashley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 1,247 | 1,247 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Ashley McEvoy A. | EVP, WW Chair, MedTech | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Aug 2023 | 2,787 | 52,037 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Ashley McEvoy A. | EVP, WW Chair, MedTech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 61,295 | 61,295 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Ashley McEvoy A. | EVP, WW Chair, MedTech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 17,994 | 61,982 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Ashley McEvoy A. | EVP, WW Chair, MedTech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.01 per share. | 13 Feb 2023 | 7,158 | 54,824 (0%) | 0% | 162.0 | 1,159,668 | Common Stock |
| Johnson & Johnson | Ashley McEvoy A. | EVP, WW Chair, MedTech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 3,704 | 3,704 | - | - | Restricted Share Units | |
| Johnson & Johnson | Ashley McEvoy A. | EVP, WW Chair, MedTech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 2,999 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Ashley McEvoy A. | EVP, WW Chair, MedTech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 2,999 | 44,811 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Ashley McEvoy A. | EVP, WW Chair, MedTech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.08 per share. | 10 Feb 2023 | 823 | 43,988 (0%) | 0% | 162.1 | 133,392 | Common Stock |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, MedTech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2022 | 73,323 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, MedTech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.54 per share. | 30 Nov 2022 | 73,323 | 115,135 (0%) | 0% | 72.5 | 5,318,850 | Common Stock |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, MedTech | Sale of securities on an exchange or to another person at price $ 175.46 per share. | 30 Nov 2022 | 71,923 | 41,812 (0%) | 0% | 175.5 | 12,619,272 | Common Stock |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, MedTech | Sale of securities on an exchange or to another person at price $ 176.09 per share. | 30 Nov 2022 | 1,400 | 113,735 (0%) | 0% | 176.1 | 246,529 | Common Stock |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, Medical Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 66,110 | 66,110 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, Medical Devices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 15,806 | 1,506 | - | - | Performance Share Units | |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, Medical Devices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 15,806 | 48,054 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, Medical Devices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.89 per share. | 14 Feb 2022 | 6,242 | 41,812 (0%) | 0% | 165.9 | 1,035,485 | Common Stock |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, Medical Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 3,347 | 3,347 | - | - | Restricted Share Units | |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, Medical Devices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 2,885 | 33,040 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, Medical Devices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 2,885 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Ashley McEvoy | EVP, WW Chair, Medical Devices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 168.85 per share. | 14 Feb 2022 | 792 | 32,248 (0%) | 0% | 168.8 | 133,729 | Common Stock |